Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann T Farrell

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
The Oncologist|March 29, 2005
FDA drug approval summary: azacitidine (5-azacytidine, Vidaza) for injectable suspensionEdvardas Kaminskas, Ann T Farrell, Yong-Cheng Wang, et al.
Blood Reviews|April 4, 2020
Older adults in hematologic malignancy trials: Representation, barriers to participation and strategies for addressing underrepresentationBindu Kanapuru, Harpreet Singh, Virginia Kwitkowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2013
Gemtuzumab ozogamicinDonna Przepiorka, Albert Deisseroth, Robert Kane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2008
Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trialsChristopher K Daugherty, Mark J Ratain, Ezekiel J Emanuel, et al.
Oncology (Williston Park, N.Y.)|December 15, 2007
Liposomal doxorubicin in combination with bortezomib for relapsed or refractory multiple myelomaYang-Min Ning, Kun He, Ramzi Dagher, et al.
The Oncologist|April 26, 2017
FDA Approval Summary: Nivolumab for the Treatment of Relapsed or Progressive Classical Hodgkin LymphomaYvette L Kasamon, R Angelo de Claro, Yaping Wang, et al.
Pediatric Blood & Cancer|June 20, 2017
U.S. Food and Drug Administration approval summary: Eltrombopag for the treatment of pediatric patients with chronic immune (idiopathic) thrombocytopeniaLori A Ehrlich, Virginia E Kwitkowski, Gregory Reaman, et al.
The Oncologist|February 14, 2018
FDA Approval Summary: Lenalidomide as Maintenance Therapy After Autologous Stem Cell Transplant in Newly Diagnosed Multiple MyelomaElizabeth Dianne Pulte, Andrew Dmytrijuk, Lei Nie, et al.
The Oncologist|January 16, 2009
Sorafenib for the treatment of unresectable hepatocellular carcinomaRobert C Kane, Ann T Farrell, Rajanikanth Madabushi, et al.
The Oncologist|March 25, 2010
FDA approval summary: temsirolimus as treatment for advanced renal cell carcinomaVirginia E Kwitkowski, Tatiana M Prowell, Amna Ibrahim, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
The Oncologist|March 29, 2005
FDA drug approval summary: azacitidine (5-azacytidine, Vidaza) for injectable suspensionEdvardas Kaminskas, Ann T Farrell, Yong-Cheng Wang, et al.
Blood Reviews|April 4, 2020
Older adults in hematologic malignancy trials: Representation, barriers to participation and strategies for addressing underrepresentationBindu Kanapuru, Harpreet Singh, Virginia Kwitkowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2013
Gemtuzumab ozogamicinDonna Przepiorka, Albert Deisseroth, Robert Kane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2008
Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trialsChristopher K Daugherty, Mark J Ratain, Ezekiel J Emanuel, et al.
Oncology (Williston Park, N.Y.)|December 15, 2007
Liposomal doxorubicin in combination with bortezomib for relapsed or refractory multiple myelomaYang-Min Ning, Kun He, Ramzi Dagher, et al.
The Oncologist|April 26, 2017
FDA Approval Summary: Nivolumab for the Treatment of Relapsed or Progressive Classical Hodgkin LymphomaYvette L Kasamon, R Angelo de Claro, Yaping Wang, et al.
Pediatric Blood & Cancer|June 20, 2017
U.S. Food and Drug Administration approval summary: Eltrombopag for the treatment of pediatric patients with chronic immune (idiopathic) thrombocytopeniaLori A Ehrlich, Virginia E Kwitkowski, Gregory Reaman, et al.
The Oncologist|February 14, 2018
FDA Approval Summary: Lenalidomide as Maintenance Therapy After Autologous Stem Cell Transplant in Newly Diagnosed Multiple MyelomaElizabeth Dianne Pulte, Andrew Dmytrijuk, Lei Nie, et al.
The Oncologist|January 16, 2009
Sorafenib for the treatment of unresectable hepatocellular carcinomaRobert C Kane, Ann T Farrell, Rajanikanth Madabushi, et al.
The Oncologist|March 25, 2010
FDA approval summary: temsirolimus as treatment for advanced renal cell carcinomaVirginia E Kwitkowski, Tatiana M Prowell, Amna Ibrahim, et al.
Pageof 6